Want to see AU:GLH full AI Analyst Report?
GLH Stock Chart & Stats
AU$0.09
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.09
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.05 - AU$0.14
Previous CloseN/A
Volume20.61K
Average Volume (3M)18.95K
Market Cap
AU$3.53M
Enterprise ValueAU$337.87B
Total Cash (Recent Filing)AU$1.04M
Total Debt (Recent Filing)AU$1.63M
Price to Earnings (P/E)65.0
Beta0.11
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding58,794,537
10 Day Avg. Volume15,411
30 Day Avg. Volume18,951
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)-1.06
Price to Sales (P/S)0.46
P/FCF Ratio-5.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthTop-line expanded materially over several years, showing the core business can regain and grow customer traction. Durable revenue growth supports absorption of fixed costs, provides a larger base for margin improvement, and increases optionality for scale-driven profitability over 2–6 months.
Gross Margin RecoveryA structural rebound in gross margin signals operational improvements or pricing/mix shifts that can persist beyond short-term cycles. Sustained mid-20% gross margins materially improve the company’s ability to move toward operating profitability as revenues continue to rise.
Improving Cash Burn TrendSharply reduced operating cash outflows indicate improving cash conversion and cost discipline. A consistent downward trend in burn reduces near-term refinancing pressure and increases the likelihood the company can reach sustainable positive cash flow within a medium-term horizon.
Bears Say
Negative Shareholders' EquityPersistently negative equity reflects cumulative losses and weak capital structure, raising solvency and refinancing risk. It constrains strategic flexibility, makes new capital more dilutive or costly, and heightens the chance of restructuring if operating improvements stall.
Ongoing Negative Operating Cash FlowContinued negative operating cash flow, despite improvement, means the company still relies on external funding or balance-sheet fixes to sustain operations. Persistent cash deficits limit reinvestment, raise financing needs, and increase capital-raising risk over the next several quarters.
Continued Operating LossesThe business remains loss-making at the operating and net levels, showing that margin recovery hasn't yet delivered profitability. Ongoing losses reduce internal funding capacity, prolong reliance on external capital, and make sustainable scaling sensitive to cost or demand setbacks.
GLH FAQ
What was Global Health Limited’s price range in the past 12 months?
Global Health Limited lowest share price was AU$0.05 and its highest was AU$0.14 in the past 12 months.
What is Global Health Limited’s market cap?
Global Health Limited’s market cap is AU$3.53M.
When is Global Health Limited’s upcoming earnings report date?
Global Health Limited’s upcoming earnings report date is Sep 02, 2026 which is in 58 days.
How were Global Health Limited’s earnings last quarter?
Global Health Limited released its earnings results on Feb 25, 2026. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
Is Global Health Limited overvalued?
According to Wall Street analysts Global Health Limited’s price is currently Overvalued.
Does Global Health Limited pay dividends?
Global Health Limited pays a Quarterly dividend of AU$0.01 which represents an annual dividend yield of N/A. See more information on Global Health Limited dividends here
What is Global Health Limited’s EPS estimate?
Global Health Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Health Limited have?
Global Health Limited has 58,794,537 shares outstanding.
What happened to Global Health Limited’s price movement after its last earnings report?
Global Health Limited reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Global Health Limited?
Currently, no hedge funds are holding shares in AU:GLH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Global Health Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:GLH Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-37.50%
12-Months-Change
Fundamentals
Return on Equity
15.41%
Trailing 12-Months
Asset Growth
-1.19%
Trailing 12-Months
Company Description
Global Health Limited
Headquartered in Melbourne, Australia, and established in 1985, Global Health Limited develops and supplies digital health solutions for the Australian healthcare sector. Their comprehensive suite of software addresses various needs, including specialized platforms for mental health practitioners like psychologists and psychiatrists. The company provides integrated solutions across community health and human services, encompassing areas such as drug and alcohol support, disability services, post-acute and community care, and rehabilitation. Furthermore, they offer solutions for home and aged care, general practice, pharmacies, and consumer engagement. Key products include the MasterCare Electronic Medical Record (EMR), MasterCare + for digitizing services, and MasterCare Patient Administration System (PAS). PrimaryClinic provides medical and practice management capabilities for GPs and specialists, enabling shared patient demographic data. Other significant tools are ReferralNet for secure document exchange, LifeCard as a personal health record, and HotHealth for digital patient engagement. Complementing these are the MasterCare Data Warehouse for streamlined data analysis, e-switch middleware for seamless system integration, a Patient Portal for digital pre-admission data capture, and Altitude, their cloud hosting service.
Technical Analysis
Epsilon Healthcare Limited
―
Ramsay Health Care
―
Paragon Care Limited
―
Regis Healthcare Ltd.
―
Freedom Care Group Holdings Limited
―







